Medicare Enrolled
Dr. Andrei Serbanescu, M.D.
Neurology · Atlanta, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Serbanescu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Serbanescu?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Serbanescu
Dr. Andrei Serbanescu is a neurology specialist in Atlanta, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Serbanescu performed 10,531 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Serbanescu received a total of $230,571 from 61 pharmaceutical and/or device companies across 657 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Serbanescu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 11% volume in GA
$230,571 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗10,531
Medicare services
Top 11% in GA for neurology
Not available
Unique patients (not deduplicated)
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
9,850 | $5 | $21 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
254 | $84 | $374 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
163 | $59 | $258 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
123 | $113 | $549 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
34 | $113 | $548 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
31 | $60 | $239 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
27 | $57 | $168 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
22 | $95 | $352 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
16 | $78 | $324 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
11 | $62 | $349 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$230,571
Total received (2018-2024)
Avg $32,939/year across 7 years
Top 4% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
657
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,053
2023
$14,794
2022
$13,517
2021
$28,577
2020
$25,122
2019
$70,927
2018
$75,581
Payments by company (2024)
Alexion Pharmaceuticals, Inc.
$429
ABBVIE INC.
$285
UCB, Inc.
$198
Novartis Pharmaceuticals Corporation
$160
PFIZER INC.
$116
ACADIA Pharmaceuticals Inc
$96
Lilly USA, LLC
$84
Amgen Inc.
$83
ARGENX US, INC.
$54
MDD US Operations, LLC
$49
Otsuka America Pharmaceutical, Inc.
$47
EMD Serono, Inc.
$45
Cycle Pharmaceuticals Inc
$36
SK Life Science, Inc.
$34
Biogen, Inc.
$34
Acorda Therapeutics, Inc
$29
Lundbeck LLC
$29
Alnylam Pharmaceuticals Inc.
$29
Amneal Pharmaceuticals LLC
$28
Teva Pharmaceuticals USA, Inc.
$28
Vanda Pharmaceuticals Inc.
$25
Neurocrine Biosciences, Inc.
$25
Eisai Inc.
$24
Genentech USA, Inc.
$24
ANI Pharmaceuticals, Inc.
$23
Kedrion Biopharma, Inc.
$22
SCILEX PHARMACEUTICALS INC.
$19
Top 3 companies account for 44.4% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$60,061
EMD Serono, Inc.
$58,536
Lilly USA, LLC
$26,028
GENZYME CORPORATION
$20,430
Celgene Corporation
$15,251
Teva Pharmaceuticals USA, Inc.
$14,164
AbbVie Inc.
$13,382
NOVARTIS PHARMACEUTICALS CORPORATION
$6,405
E.R. Squibb & Sons, L.L.C.
$5,686
ABBVIE INC.
$3,698
Biogen, Inc.
$1,818
Alexion Pharmaceuticals, Inc.
$837
Novartis Pharmaceuticals Corporation
$758
Allergan, Inc.
$750
UCB, Inc.
$573
ACADIA Pharmaceuticals Inc
$308
Biohaven Pharmaceuticals, Inc.
$167
PFIZER INC.
$165
SK Life Science, Inc.
$133
Lundbeck LLC
$91
Genentech USA, Inc.
$89
W. L. Gore & Associates, Inc.
$71
Biohaven Pharmaceutical Holding Company Ltd.
$62
Amneal Pharmaceuticals LLC
$61
Horizon Therapeutics plc
$59
ARGENX US, INC.
$54
Neurocrine Biosciences, Inc.
$50
MDD US Operations, LLC
$49
Otsuka America Pharmaceutical, Inc.
$47
Eisai Inc.
$43
Supernus Pharmaceuticals, Inc.
$42
Adamas Pharmaceuticals, Inc.
$38
Cycle Pharmaceuticals Inc
$36
Vertical Pharmaceuticals, LLC
$34
ARBOR PHARMACEUTICALS, INC.
$32
CSL Behring
$30
Acorda Therapeutics, Inc
$29
Alnylam Pharmaceuticals Inc.
$29
Exelixis Inc.
$28
BANNER LIFE SCIENCES, LLC
$27
IMPEL PHARMACEUTICALS INC.
$27
Harmony Biosciences LLC
$26
Impax Laboratories, Inc.
$26
Vanda Pharmaceuticals Inc.
$25
Neurelis, Inc.
$24
ANI Pharmaceuticals, Inc.
$23
Bausch Health US, LLC
$23
Kedrion Biopharma, Inc.
$22
UPSHER-SMITH LABORATORIES LLC
$22
JAZZ PHARMACEUTICALS INC.
$22
Akcea Therapeutics, Inc.
$21
MITSUBISHI TANABE PHARMA AMERICA, INC.
$20
Kyowa Kirin, Inc.
$20
Taiho Oncology, Inc.
$19
SCILEX PHARMACEUTICALS INC.
$19
Cala Health, Inc.
$18
Merck Sharp & Dohme Corporation
$15
Promius Pharma LLC
$14
Sunovion Pharmaceuticals Inc.
$13
Clovis Oncology, Inc.
$12
US WorldMeds, LLC
$10
Top 3 companies account for 62.7% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · AMVUTTRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Albuked · Austedo XR · BAFIERTAM · BELSOMRA · BOTOX · Briviact · CALA TRIO · COMIRNATY · COPAXONE · Cabometyx · DUOPA · ELYXYB - CELECOXIB · EMGALITY · GILENYA · GOCOVRI · GORE CARDIOFORM Septal Occluder · Gocovri · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · LEMTRADA · Leqembi · Lonsurf · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · NORTHERA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · OCREVUS · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · Ozanimod · PONVORY · PURIFIED CORTROPHIN GEL · QULIPTA · RADICAVA · RELEXXII · REXULTI · RINVOQ · RYTARY · Rebif · Rubraca · SOLIRIS · Soliris · TEGSEDI · TYSABRI · Tascenso ODT · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VYEPTI · VYVGART · VYVGART HYTRULO · WAKIX · XYREM · Xadago · ZEMBRACE SYMTOUCH · ZEPOSIA · Zembrace · Zilbrysq
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
233
County median income
$91,490
Nearest hospital to ZIP centroid (approximate)
EMORY UNIVERSITY HOSPITAL MIDTOWN
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Serbanescu is a mixed practice specialist, with above-average Medicare volume (top 11% in GA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Serbanescu experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Serbanescu performed 9,850 botox injection, per unit services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Serbanescu receive payments from pharmaceutical companies?
Yes. Dr. Serbanescu received a total of $230,571 from 61 companies across 657 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Serbanescu's costs compare to other neurologists in Atlanta?
Dr. Serbanescu's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Serbanescu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Atlanta
Browse neurologists in Atlanta ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in GA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in GA
Which GA neurologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
EMD Serono, Inc. Payments to Doctors
See all physicians who received payments from EMD Serono, Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology